目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global nontuberculous mycobacterial infections market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global nontuberculous mycobacterial infections market 2018 - 2022 ($ billion)
4.2 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacies - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
6.4 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
6.5 Online pharmacies - Market size and forecast 2023-2028
Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ billion)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Product
7.1 Market segments
Exhibit 48: Chart on Product - Market share 2023-2028 (%)
Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 Clarithromycin - Market size and forecast 2023-2028
Exhibit 52: Chart on Clarithromycin - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Clarithromycin - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Clarithromycin - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Clarithromycin - Year-over-year growth 2023-2028 (%)
7.4 Azithromycin - Market size and forecast 2023-2028
Exhibit 56: Chart on Azithromycin - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Azithromycin - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Azithromycin - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Azithromycin - Year-over-year growth 2023-2028 (%)
7.5 Rifampin - Market size and forecast 2023-2028
Exhibit 60: Chart on Rifampin - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Rifampin - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Rifampin - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Rifampin - Year-over-year growth 2023-2028 (%)
7.6 Rifabutin - Market size and forecast 2023-2028
Exhibit 64: Chart on Rifabutin - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Rifabutin - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Rifabutin - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Rifabutin - Year-over-year growth 2023-2028 (%)
7.7 Others - Market size and forecast 2023-2028
Exhibit 68: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 70: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Product
Exhibit 72: Market opportunity by Product ($ billion)
Exhibit 73: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share by geography 2023-2028 (%)
Exhibit 76: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Japan - Market size and forecast 2023-2028
Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.10 Germany - Market size and forecast 2023-2028
Exhibit 107: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 111: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 112: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 113: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 115: Market opportunity by geography ($ billion)
Exhibit 116: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 123: Abbott Laboratories - Overview
Exhibit 124: Abbott Laboratories - Business segments
Exhibit 125: Abbott Laboratories - Key news
Exhibit 126: Abbott Laboratories - Key offerings
Exhibit 127: Abbott Laboratories - Segment focus
12.4 Astellas Pharma Inc.
Exhibit 128: Astellas Pharma Inc. - Overview
Exhibit 129: Astellas Pharma Inc. - Product / Service
Exhibit 130: Astellas Pharma Inc. - Key news
Exhibit 131: Astellas Pharma Inc. - Key offerings
12.5 Cipla Ltd.
Exhibit 132: Cipla Ltd. - Overview
Exhibit 133: Cipla Ltd. - Business segments
Exhibit 134: Cipla Ltd. - Key news
Exhibit 135: Cipla Ltd. - Key offerings
Exhibit 136: Cipla Ltd. - Segment focus
12.6 Glenmark Pharmaceuticals Ltd.
Exhibit 137: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 138: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 139: Glenmark Pharmaceuticals Ltd. - Key offerings
12.7 Hikma Pharmaceuticals Plc
Exhibit 140: Hikma Pharmaceuticals Plc - Overview
Exhibit 141: Hikma Pharmaceuticals Plc - Business segments
Exhibit 142: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 143: Hikma Pharmaceuticals Plc - Segment focus
12.8 Insmed Inc.
Exhibit 144: Insmed Inc. - Overview
Exhibit 145: Insmed Inc. - Product / Service
Exhibit 146: Insmed Inc. - Key offerings
12.9 Johnson and Johnson
Exhibit 147: Johnson and Johnson - Overview
Exhibit 148: Johnson and Johnson - Business segments
Exhibit 149: Johnson and Johnson - Key news
Exhibit 150: Johnson and Johnson - Key offerings
Exhibit 151: Johnson and Johnson - Segment focus
12.10 Lupin Ltd.
Exhibit 152: Lupin Ltd. - Overview
Exhibit 153: Lupin Ltd. - Product / Service
Exhibit 154: Lupin Ltd. - Key news
Exhibit 155: Lupin Ltd. - Key offerings
12.11 Pfizer Inc.
Exhibit 156: Pfizer Inc. - Overview
Exhibit 157: Pfizer Inc. - Product / Service
Exhibit 158: Pfizer Inc. - Key news
Exhibit 159: Pfizer Inc. - Key offerings
12.12 QIAGEN NV
Exhibit 160: QIAGEN NV - Overview
Exhibit 161: QIAGEN NV - Product / Service
Exhibit 162: QIAGEN NV - Key news
Exhibit 163: QIAGEN NV - Key offerings
12.13 Sanofi SA
Exhibit 164: Sanofi SA - Overview
Exhibit 165: Sanofi SA - Business segments
Exhibit 166: Sanofi SA - Key news
Exhibit 167: Sanofi SA - Key offerings
Exhibit 168: Sanofi SA - Segment focus
12.14 Sun Pharmaceutical Industries Ltd.
Exhibit 169: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 170: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 171: Sun Pharmaceutical Industries Ltd. - Key offerings
12.15 Teva Pharmaceutical Industries Ltd.
Exhibit 172: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 173: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 176: Teva Pharmaceutical Industries Ltd. - Segment focus
12.16 Viatris Inc.
Exhibit 177: Viatris Inc. - Overview
Exhibit 178: Viatris Inc. - Business segments
Exhibit 179: Viatris Inc. - Key news
Exhibit 180: Viatris Inc. - Key offerings
Exhibit 181: Viatris Inc. - Segment focus
12.17 Zydus Lifesciences Ltd.
Exhibit 182: Zydus Lifesciences Ltd. - Overview
Exhibit 183: Zydus Lifesciences Ltd. - Business segments
Exhibit 184: Zydus Lifesciences Ltd. - Key offerings
Exhibit 185: Zydus Lifesciences Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 186: Inclusions checklist
Exhibit 187: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 188: Currency conversion rates for US$
13.4 Research methodology
Exhibit 189: Research methodology
Exhibit 190: Validation techniques employed for market sizing
Exhibit 191: Information sources
13.5 List of abbreviations
Exhibit 192: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global nontuberculous mycobacterial infections market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Distribution Channel ($ billion)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits48: Chart on Product - Market share 2023-2028 (%)
Exhibits49: Data Table on Product - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Clarithromycin - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Clarithromycin - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Clarithromycin - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Clarithromycin - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Azithromycin - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Azithromycin - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Azithromycin - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Azithromycin - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Rifampin - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Rifampin - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Rifampin - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Rifampin - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Rifabutin - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Rifabutin - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Rifabutin - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Rifabutin - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits72: Market opportunity by Product ($ billion)
Exhibits73: Data Table on Market opportunity by Product ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share by geography 2023-2028 (%)
Exhibits76: Data Table on Market share by geography 2023-2028 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits112: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits113: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits115: Market opportunity by geography ($ billion)
Exhibits116: Data Tables on Market opportunity by geography ($ billion)
Exhibits117: Impact of drivers and challenges in 2023 and 2028
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Abbott Laboratories - Overview
Exhibits124: Abbott Laboratories - Business segments
Exhibits125: Abbott Laboratories - Key news
Exhibits126: Abbott Laboratories - Key offerings
Exhibits127: Abbott Laboratories - Segment focus
Exhibits128: Astellas Pharma Inc. - Overview
Exhibits129: Astellas Pharma Inc. - Product / Service
Exhibits130: Astellas Pharma Inc. - Key news
Exhibits131: Astellas Pharma Inc. - Key offerings
Exhibits132: Cipla Ltd. - Overview
Exhibits133: Cipla Ltd. - Business segments
Exhibits134: Cipla Ltd. - Key news
Exhibits135: Cipla Ltd. - Key offerings
Exhibits136: Cipla Ltd. - Segment focus
Exhibits137: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits138: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits139: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits140: Hikma Pharmaceuticals Plc - Overview
Exhibits141: Hikma Pharmaceuticals Plc - Business segments
Exhibits142: Hikma Pharmaceuticals Plc - Key offerings
Exhibits143: Hikma Pharmaceuticals Plc - Segment focus
Exhibits144: Insmed Inc. - Overview
Exhibits145: Insmed Inc. - Product / Service
Exhibits146: Insmed Inc. - Key offerings
Exhibits147: Johnson and Johnson - Overview
Exhibits148: Johnson and Johnson - Business segments
Exhibits149: Johnson and Johnson - Key news
Exhibits150: Johnson and Johnson - Key offerings
Exhibits151: Johnson and Johnson - Segment focus
Exhibits152: Lupin Ltd. - Overview
Exhibits153: Lupin Ltd. - Product / Service
Exhibits154: Lupin Ltd. - Key news
Exhibits155: Lupin Ltd. - Key offerings
Exhibits156: Pfizer Inc. - Overview
Exhibits157: Pfizer Inc. - Product / Service
Exhibits158: Pfizer Inc. - Key news
Exhibits159: Pfizer Inc. - Key offerings
Exhibits160: QIAGEN NV - Overview
Exhibits161: QIAGEN NV - Product / Service
Exhibits162: QIAGEN NV - Key news
Exhibits163: QIAGEN NV - Key offerings
Exhibits164: Sanofi SA - Overview
Exhibits165: Sanofi SA - Business segments
Exhibits166: Sanofi SA - Key news
Exhibits167: Sanofi SA - Key offerings
Exhibits168: Sanofi SA - Segment focus
Exhibits169: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits170: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits171: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits172: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits173: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits174: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits175: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits176: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits177: Viatris Inc. - Overview
Exhibits178: Viatris Inc. - Business segments
Exhibits179: Viatris Inc. - Key news
Exhibits180: Viatris Inc. - Key offerings
Exhibits181: Viatris Inc. - Segment focus
Exhibits182: Zydus Lifesciences Ltd. - Overview
Exhibits183: Zydus Lifesciences Ltd. - Business segments
Exhibits184: Zydus Lifesciences Ltd. - Key offerings
Exhibits185: Zydus Lifesciences Ltd. - Segment focus
Exhibits186: Inclusions checklist
Exhibits187: Exclusions checklist
Exhibits188: Currency conversion rates for US$
Exhibits189: Research methodology
Exhibits190: Validation techniques employed for market sizing
Exhibits191: Information sources
Exhibits192: List of abbreviations